AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Feb 26, 2016
30071_dirs_2016-02-26_e5311d1f-518d-441c-9cd8-cdd00893b10e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-02-23
Reporting Person: Reiser Anne (President - ResMed Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-23 | ResMed Common Stock | M | 3000 | $20.355 | Acquired | 79300.126 | Direct |
| 2016-02-23 | ResMed Common Stock | F | 1054 | $57.94 | Disposed | 78246.126 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-23 | ResMed Common Stock Options | $20.355 | M | 3000 | Disposed | 2016-02-23 | ResMed Commmon Stock (3000) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.
F2: Disposition to issuer for payment of cost of equity security by netting of shares from expiring stock options granted on 2/23/2016.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29